PeptideDB

AKT-IN-18

CAS: F: C19H14ClN5O2S W: 411.86

AKT-IN-18, an inhibitor of Akt, inhibits Akt with an IC50 of 69.45 μΜ in A549 cells. AKT-IN-18 induces apoptosis and c
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity AKT-IN-18, an inhibitor of Akt, inhibits Akt with an IC50 of 69.45 μΜ in A549 cells. AKT-IN-18 induces apoptosis and can be used in non-small cell lung cancer study[1].
Invitro AKT-IN-18 (Compound 3i) (0-500 μM;24 小时) 对 A549 细胞具有细胞毒性,并诱导细胞凋亡[1]。 Apoptosis Analysis[1] Cell Line:
Name AKT-IN-18
Formula C19H14ClN5O2S
Molar Mass 411.86
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Erdönmez B,et.al. Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS Omega. 2023 May 24;8(22):20056-20065.